The Great American Smokeout

The Great American Smokeout

November 16th, 2017 by

Today, November 16th, is The Great American Smokeout, an annual event run by the American Cancer Society to encourage smokers across the nation to quit. Although smoking rates in the US are dropping, around 36.5 million Americans still smoke cigarettes. Tobacco use remains the single largest preventable cause of disease and premature death in the world, […]

Nerudia Acquired by Fontem Ventures

November 9th, 2017 by

Fontem Ventures, owner of market leading electronic vapour brand blu, and part of the Imperial Brands PLC portfolio, has acquired Nerudia. Fontem is focused on the rapidly growing e-vapour sector, and blu is one of the leading EVP brands in the UK, USA, France and Italy. The acquisition of Nerudia further enhances Fontem’s capabilities in […]

EU and US align GMP inspections

November 1st, 2017 by

Today, 1st November 2017, the European Medicines Agency (EMA) issued a press release announcing that the long awaited mutual recognition agreement between the European Union (EU) and the United States (US), to recognise inspections of manufacturing sites for human medicines in their respective territories, came into effect. This milestone follows confirmation by the EU, in […]

UK MPs launch enquiry to examine the impact of e-cigarettes

October 25th, 2017 by

A new enquiry by the Science and Technology Committee will examine the impact of electronic cigarettes on human health, including how effective they are as a tool to help people stop smoking. The enquiry will also look at the suitability of regulations covering e-cigarettes as well as the financial implications of the growing market. An […]

Update from TOPRA 2017 Annual Symposium

October 10th, 2017 by

The TOPRA Annual Symposium is seen as one of the most important events for European regulatory professionals, as the largest forum to discuss current regulatory issues and debate the future of regulations. Last week Nerudia attended the symposium which focused on ‘Global regulatory approaches to improving healthcare.’ There are significant changes ahead for medicinal products […]

Sign up for our newsletter